Literature DB >> 12739050

[Vasculitides: classification, clinical aspects and pathology. A review].

Peter Meister.   

Abstract

The Consensus Conference of Chapel Hill (1994) laid a common base for a standardized classification of vasculitides which, after a pre-existing historical diversity, enabled a comparison of different studies. The criteria for this classification are foremost anatomico-pathological and are based on the caliber of affected blood vessels. In addition the quality of the inflammatory reaction, and the entirety of clinical symptoms, as well as the results of immunological tests are included. Moreover a unified pathogenetic concept is proposed for all types of vasculitis. The diagnosis of vasculitis of large, medium or small vessels is made primarily by biopsies and examination of HE-stained sections. However, overlap of calibers of vessels affected and lack of specificity of inflammatory reaction with individual vasculitis types have to be paid attention to. Immunohistochemical methods are only rarely routinely applied. In contrast the complete clinical picture and the results of immunological laboratory tests (especially AntiNeutrophilCytoplasmicAntibodies, ANCA) play an important role in the differential diagnosis of various vasculitis types. Definitions, clinical findings and pathology of the various types of vasculitis are described. Also mentioned are secondary vasculitides, e.g concurrent to collagen diseases or infections. Not only the diagnosis of vasculitis but also the recognition of the specific type and, last but not least monitoring by histological controls, may be decisive for an optimal therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12739050     DOI: 10.1007/s00292-003-0618-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

1.  A case of Wegener's granulomatosis without granulomas and with a negative C-ANCA.

Authors:  Shema Ahmad; David Reed; Valee Harisdangkul
Journal:  J Miss State Med Assoc       Date:  2002-04

2.  [Giant-cell arteritis].

Authors:  P Meister; P Weisweiler; H V Tuczek
Journal:  Med Welt       Date:  1975-04-18

Review 3.  Could a herpesvirus be the cause of Kawasaki disease?

Authors:  D Shingadia; A Bose; R Booy
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

Review 4.  ANCA-positive vasculitis.

Authors:  Lavanya Kamesh; Lorraine Harper; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

Review 5.  Antibodies directed against the cytoplasm of neutrophils and monocytes.

Authors:  F J van der Woude; M R Daha; W A van den Wall Bake; L A van Es
Journal:  Adv Nephrol Necker Hosp       Date:  1990

6.  Systemic vasculitis with coexistent large and small vessel involvement. A classification dilemma.

Authors:  R D deShazo; A I Levinson; O J Lawless; G Weisbaum
Journal:  JAMA       Date:  1977-10-31       Impact factor: 56.272

Review 7.  Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.

Authors:  J Sánchez-Guerrero; S Gutiérrez-Ureña; A Vidaller; E Reyes; A Iglesias; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

8.  [Vasculitis--aspect of cellular and molecular pathogenesis].

Authors:  H J Gröne
Journal:  Verh Dtsch Ges Pathol       Date:  2001

9.  [Atherosclerosis--search for a new entity].

Authors:  H A Lehr; C J Kirkpatrick
Journal:  Verh Dtsch Ges Pathol       Date:  2001

10.  The clinical, serologic, and immunopathologic heterogeneity of cutaneous leukocytoclastic angiitis.

Authors:  J C Jennette; R Tuttle; R J Falk
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

View more
  2 in total

Review 1.  [Vasculopathy in Sjögren's syndrome].

Authors:  E Feist; K-G A Hermann; A Dankof
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

Review 2.  [Histology of cutaneous vasculitides].

Authors:  A Stein; I Hackert; M Meurer
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.